Future Care for Medical Industries (FCMI) results, Q4 2022
Net profit, assets, equity and cash flow for Q4 2022, against the same period a year earlier, from the published financial statements.
Net profit1.49 millionEGP · +412.6% vs the same period a year earlier
Total assets64.99 millionEGP · −4.4% vs the same period a year earlier
Shareholders' equity60.68 millionEGP · +0.6% vs the same period a year earlier
Operating cash flow-9.51 millionEGP · −506.8% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q4 2022 was about 1.49 million EGP, up +412.6% from 290 thousand EGP in Q4 2021.
- Total assets at the end of Q4 2022 were about 64.99 million EGP, and shareholders' equity about 60.68 million EGP.
- Operating cash flow for Q4 2022 was negative at 9.51 million EGP.
Key lines against the same period a year earlier
This periodQ4 2021Change
Net profit1.49 million290 thousand+412.6%
Gross profit2.78 million13.17 thousand+21035.7%
Total assets64.99 million67.95 million−4.4%
Total liabilities4.3 million7.61 million−43.4%
Shareholders' equity60.68 million60.34 million+0.6%
Total liabilities and equity64.99 million67.95 million−4.4%
Operating cash flow-9.51 million-1.57 million−506.8%
Investing cash flow-10.5 thousand——
Financing cash flow-327 thousand34.56 million−100.9%
Net change in cash-9.85 million34.32 million−128.7%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy